These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 277207

  • 1. The rationale for the development of improved hypoxic cell radiosensitizers.
    Wardman P, Clarke ED, Flockhart IR, Wallace RG.
    Br J Cancer Suppl; 1978 Jun; 3():1-5. PubMed ID: 277207
    [Abstract] [Full Text] [Related]

  • 2. Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.
    Watts ME, Jacobs RS.
    Br J Cancer Suppl; 1978 Jun; 3():80-3. PubMed ID: 277262
    [Abstract] [Full Text] [Related]

  • 3. The use of nitroaromatic compounds as hypoxic cell radiosensitizers.
    Wardman P.
    Curr Top Radiat Res Q; 1977 Aug; 11(4):347-98. PubMed ID: 330116
    [No Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of 1-substituted 2-nitroimidazoles: effect of partition coefficient and side-chain hydroxyl groups on radiosensitization in vitro.
    Brown DM, Parker E, Brown JM.
    Radiat Res; 1982 Apr; 90(1):98-108. PubMed ID: 7199747
    [No Abstract] [Full Text] [Related]

  • 5. Radiosensitization of hypoxic bacterial cells by nitroimidazoles of low lipophilicity: steady-state and rapid-mix studies.
    Anderson RF, Patel KB, Sehmi DS.
    Radiat Res; 1981 Mar; 85(3):496-504. PubMed ID: 6782616
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
    Workman P.
    Cancer Clin Trials; 1980 Mar; 3(3):237-51. PubMed ID: 7438321
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glutathione depletion by 2-nitroimidazole-1-acetohydroxamic acid as a radiosensitizer in hypoxic rat hepatocytes.
    Takanuki K, Igarashi T, Hata K, Hori H, Shibata T, Kitagawa H, Satoh T, Inayama S.
    Biochem Int; 1988 Jul; 17(1):155-62. PubMed ID: 3190713
    [Abstract] [Full Text] [Related]

  • 15. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
    Jin CZ, Nagasawa H, Shimamura M, Uto Y, Inayama S, Takeuchi Y, Kirk KL, Hori H.
    Bioorg Med Chem; 2004 Sep 15; 12(18):4917-27. PubMed ID: 15336271
    [Abstract] [Full Text] [Related]

  • 16. Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976.
    Adams GE, Flockhart IR, Smithen CE, Stratford IJ, Wardman P, Watts ME.
    Radiat Res; 2012 Aug 15; 178(2):AV183-9. PubMed ID: 22870968
    [No Abstract] [Full Text] [Related]

  • 17. [Interaction of electron acceptor radiosensitizers with cell reducing systems].
    Basenova AT, Voronina SS, Balmukhanov BS.
    Radiobiologiia; 1982 Aug 15; 22(6):776-80. PubMed ID: 6760241
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.
    Brown JM, Yu NY, Cory MJ, Bicknell RB, Taylor DL.
    Br J Cancer Suppl; 1978 Jun 15; 3():206-11. PubMed ID: 277229
    [Abstract] [Full Text] [Related]

  • 20. Radiosensitizers: rationale and potential.
    Brown JM.
    Cancer Treat Rep; 1981 Jun 15; 65 Suppl 2():95-102. PubMed ID: 7346152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.